Penicillin G 200mg Tablet Franchise in Ahmedabad

Beta-Lactam Antibiotic Supplier in Mumbai

Penlink 200 Tablet Distributor in Delhi

Bacterial Infection Treatment Tablet Franchise Opportunity in Bangalore

Oral Antibiotic Tablet Stockist in Hyderabad
Penicillin G 200mg Export & Manufacturing in Chandigarh

Home/Products /penicillin-g-200mg-tablet

Penlink 200 Tablet

Composition : Penicillin G (200mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Strip

Packaging : 10*10

Price : ₹1/-

Penlink 200 Tablet contains Penicillin G 200mg, a time-tested beta-lactam antibiotic indicated for the treatment of infections caused by susceptible gram-positive and select gram-negative bacteria. It helps in managing respiratory tract infections, skin and soft tissue infections, and other systemic bacterial conditions.

Penicillin G works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death and effective infection control. Its oral tablet formulation allows convenient administration while maintaining reliable antibacterial action.

For distributors and healthcare suppliers, Penlink 200 Tablet is a widely used antibacterial therapy product, commonly prescribed in hospitals, clinics, and community healthcare settings. The ongoing demand for proven antibiotics ensures consistent market movement.

Adding Penlink 200 Tablet to your oral antibacterial and anti-infective therapy segment creates strong opportunities across pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its established clinical utility, prescriber confidence, and broad therapeutic use make it a valuable addition to pharmaceutical distribution portfolios.


Read More

About the Product

Penlink 200 Tablet contains Penicillin G 200mg, a time-tested beta-lactam antibiotic indicated for the treatment of infections caused by susceptible gram-positive and select gram-negative bacteria. It helps in managing respiratory tract infections, skin and soft tissue infections, and other systemic bacterial conditions.

Penicillin G works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death and effective infection control. Its oral tablet formulation allows convenient administration while maintaining reliable antibacterial action.

For distributors and healthcare suppliers, Penlink 200 Tablet is a widely used antibacterial therapy product, commonly prescribed in hospitals, clinics, and community healthcare settings. The ongoing demand for proven antibiotics ensures consistent market movement.

Adding Penlink 200 Tablet to your oral antibacterial and anti-infective therapy segment creates strong opportunities across pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its established clinical utility, prescriber confidence, and broad therapeutic use make it a valuable addition to pharmaceutical distribution portfolios.


Common side effects may include nausea, vomiting, diarrhea, or mild skin rash. Rare but serious side effects include allergic reactions such as urticaria, angioedema, or anaphylaxis. Patients should seek immediate medical attention if signs of hypersensitivity occur.

Penlink 200 Tablet is indicated for the treatment of respiratory tract infections, skin and soft tissue infections, ear, nose and throat infections, and other bacterial infections caused by penicillin-sensitive organisms, as prescribed by a healthcare professional.

Penlink 200 Tablet should be taken exactly as prescribed and the full course completed to prevent antibiotic resistance. Patients with a known allergy to penicillins or cephalosporins must inform their doctor before use. Caution is advised in patients with renal impairment.

Store Penlink 200 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use the tablet beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation